In a new study, CHOP researchers integrate data regarding how the conditions present clinically with data on protein-protein interactions.

CHOP researchers identified an in vivo role for activated protein C (APC), which could potentially be exploited for future hemophilia A treatments.

Using a novel proteomics approach, CHOP researchers have identified a host protein that restricts herpes simplex virus 1 (HSV-1) infection.

Findings suggest that risk of fractures occurring in later life could be identified in childhood and may lead to tailored interventions.

CHOP researchers have identified knowledge gaps in the metrics currently used to measure quality in pediatric/congenital cardiac catheterization laboratories.

New Cell Models Help Researchers Study Disease Development and Growth Issues in Beckwith-Wiedemann Syndrome

Adolescent drivers were more likely to get behind the wheel post-concussion than return to exercise or organized sports, suggesting the need for evidence-based guidelines

The Friedreich’s Ataxia Center of Excellence at CHOP was awarded $1.275 million by the Friedreich’s Ataxia Research Alliance, Hamilton and Finneran families and the CureFA Foundation

CHOP researchers found the elevated biomarker in all children who tested positive for SARS-CoV-2, whether they were symptomatic for COVID-19 or not.

CHOP researchers have developed a sequencing method to detect RNA modifications that regulate RNA splicing during adenovirus infection.